Forte Biosciences (FBRX) Revenue (2017 - 2019)

Forte Biosciences (FBRX) has 3 years of Revenue data on file, last reported at $9000.0 in Q4 2019.

• On a quarterly basis, Revenue changed 0.0% year-over-year to $9000.0 in Q4 2019; TTM through Dec 2019 was $36000.0, a 99.8% decrease from a year earlier, with the FY2019 full-year figure at $36000.0, down 99.8% from the prior year.
• Revenue for Q4 2019 stood at $9000.0, roughly flat from $9000.0 in the prior quarter.
• Over the last five years, Revenue for FBRX reached as high as $18.0 million in Q3 2018 and fell as low as $9000.0 in Q1 2018.
• Historically, Revenue has averaged $1.6 million across 3 years, with a median of $9000.0 in 2018.
• Across the five-year window, Revenue surged 179990.0% in 2018 and plunged 99.95% in 2019, its largest moves.
• Year by year, Revenue stood at $10000.0 in 2017, then retreated by 10.0% to $9000.0 in 2018, then changed by 0.0% to $9000.0 in 2019.
• Per Business Quant data, the three most recent Revenue figures were $9000.0 in Q4 2019, $9000.0 in Q3 2019, and $9000.0 in Q2 2019.